The relationship between Alzheimer's disease, inflammation, the APOE genotype and neuronal integrity
Year: 2013
Type: dissertation
Study design: Observational Study
Abstract: Alzheimer's disease (AD) is a neurodegenerative disorder associated with progressive neuronal loss.Microglial cell activation in the central nervous system (CNS) may contribute to this process through the release of neurotoxic inflammatory mediators.Systemic inflammation, through signaling to the CNS, can further activate microglia and thus accelerate neurodegeneration.The apolipoprotein (APOE) ε4 allele has been associated with both an increased risk of developing AD and higher levels of inflammation.The aim of this study was to investigate the relationships between systemic inflammation, CNS inflammation, the APOE genotype, neuronal integrity and cognitive functioning in a cohort of elderly participants from the Western Cape region of South Africa.South Africa is a developing country where systemic infections are common and the ε4 allelic frequency is thought to be high.Sixty-eight cognitively healthy controls and 60 AD participants were recruited.Participants underwent a full clinical and cognitive assessment.APOE genotyping was performed and the following systemic inflammatory markers were measured: erythrocyte sedimentation rate (ESR), white cell count, monocyte count, tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), transforming growth factor-beta (TGF-β), IL-10 and osteopontin.Forty-eight control and 32 AD participants were re-assessed after one-year.Thirty-three participants underwent proton magnetic resonance spectroscopy for the detection of myo-inositol (MI), a marker of glial activation, and N-acetylaspartate and N-acetylaspartylglutamate (NAA+NAAG), a neuronal integrity marker, in the posterior cingulate gyrus.Results showed that mild AD participants had higher ESRs and IL-1β levels when compared with moderate AD, more severe AD and control participants.High baseline levels of TNF-α, low baseline levels of IL-10 and the presence of the ε4 allele were independently associated with a greater cognitive decline in AD.MI was increased in more severe AD participants and tended to be negatively correlated with episodic memory performance.NAA+NAAG levels were lower in AD participants compared with controls.In conclusion, the inflammatory response in AD changed with disease progression.Pro-inflammatory systemic changes were seen early in the disease but glial activation in the CNS was observed later.Thus, systemic inflammation may drive CNS inflammation and neurodegeneration.The ε4 allele had a detrimental effect in AD.The mechanism by which ε4 exerts its detrimental effects may relate to suppression of a protective anti-inflammatory response.
Author: Laurian Kerry Grace
Institution: University of Cape Town
Language: English
Subfield: Neurology
Field: Neuroscience
Domain: Life Sciences
Keywords: Alzheimer's disease, systemic inflammation
Open Access status: green
OpenAlex ID: W2232253360
